Tianjin Institute of Pharmaceutical Research (China)
Impact in
-
- Traditional Chinese Medicine Analysis
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
-
- Traditional Chinese Medicine Analysis 142
- Pharmacology 70
- Pharmacogenetics and Drug Metabolism 42
Tianjin Institute of Pharmaceutical Research (China)
740 papers receiving 15k citations
Peers
Comparison fields: 5 of 161
- Complementary and alternative medicine 2.6k
- Pharmaceutical Science 1.1k
- Drug Discovery 36
- Biomaterials 1.5k
- Pharmacology 907
Countries citing scholars working at Tianjin Institute of Pharmaceutical Research (China)
This map shows the geographic impact of research produced by authors working at Tianjin Institute of Pharmaceutical Research (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Tianjin Institute of Pharmaceutical Research (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianjin Institute of Pharmaceutical Research (China) more than expected).
Fields of papers published by authors at Tianjin Institute of Pharmaceutical Research (China)
This network shows the impact of papers affiliated with Tianjin Institute of Pharmaceutical Research (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Tianjin Institute of Pharmaceutical Research (China) at the time of their publication.
About Tianjin Institute of Pharmaceutical Research (China)
In recent decades, authors affiliated with Tianjin Institute of Pharmaceutical Research (China) have published 770 papers, which have received a total of 15k indexed citations . Scholars at this organization have produced 160 papers in Complementary and alternative medicine, 70 papers in Pharmacology, 48 papers in Pharmaceutical Science, 56 papers in Analytical Chemistry and 1 paper in Drug Discovery on the topics of Traditional Chinese Medicine Analysis (142 papers), Analytical Methods in Pharmaceuticals (53 papers), Pharmacogenetics and Drug Metabolism (42 papers), Phytochemistry and Biological Activities (40 papers), Nanoparticle-Based Drug Delivery (38 papers), Drug Transport and Resistance Mechanisms (37 papers), Computational Drug Discovery Methods (36 papers) and Drug Solubulity and Delivery Systems (28 papers). Their work is cited by papers focused on Complementary and alternative medicine (2.6k citations), Pharmaceutical Science (1.1k citations), Drug Discovery (36 citations), Biomaterials (1.5k citations) and Pharmacology (907 citations). Authors at Tianjin Institute of Pharmaceutical Research (China) collaborate with scholars in China, United States and Macao and have published in prestigious journals including Journal of Chromatography B, Biomedical Chromatography, Phytomedicine, Chinese Chemical Letters and Journal of Ethnopharmacology. Some of Tianjin Institute of Pharmaceutical Research (China)'s most productive authors include Changxiao Liu, Weiren Xu, Fancui Meng, Zhonggui He, Cong Luo, Duanyun Si, Wei Ping Jia, Yazhuo Li, Wenyuan Gao and De‐an Guo.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.